94 related articles for article (PubMed ID: 8545441)
1. [Pharmaco-epidemiologic evaluation of rilmenidine in 18,235 hypertensive patients].
Luccioni R
Presse Med; 1995 Dec; 24(38):1857-64. PubMed ID: 8545441
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and acceptability of rilmenidine in a population of 2 738 hypertensive diabetic patients].
Kourilsky O; Meurin P
Presse Med; 2002 Nov; 31(39 Pt 1):1864-8. PubMed ID: 12496718
[TBL] [Abstract][Full Text] [Related]
3. Dose-effect relationship of rilmenidine after chronic administration.
Luccioni R; Lambert M; Ambrosi P; Scemama M
Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
[TBL] [Abstract][Full Text] [Related]
4. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.
Lins RL; Daelemans R; Dratwa M; Verbeelen D; Sennesael J; Brisgand B; Lameire N
Am J Med; 1989 Sep; 87(3C):41S-45S. PubMed ID: 2782326
[TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Widimský J; Sirotiaková J
Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
[TBL] [Abstract][Full Text] [Related]
8. Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril.
Bauduceau B; Mayaudon H; Dupuy O
J Cardiovasc Risk; 2000 Feb; 7(1):57-61. PubMed ID: 10785875
[TBL] [Abstract][Full Text] [Related]
9. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
10. [Essential arterial hypertension treated with rilmenidin : what dose for what patient?].
Amah G
Presse Med; 1999 Jan; 28(1):11-6. PubMed ID: 9951504
[TBL] [Abstract][Full Text] [Related]
11. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Scemama M; Février B; Beucler I; Dairou F
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
Widimský J
Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with rilmenidine 1 mg per day: time-lag to maximum response. A multicenter ambulatory study. Le Groupe Français d'étude Multicentrique d'Hyperium].
Passeron J; Guillet C
Presse Med; 1992 Dec; 21(43):2089-93. PubMed ID: 1297118
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.
Buranakitjaroen P; Kittipawong P; Koanantakul B; Piamsomboon C; Prasassarakich N; Silaraks S; Sukonthasarn A; Tiyapant A;
J Med Assoc Thai; 2003 Oct; 86(10):903-10. PubMed ID: 14650701
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
Fiorentini C; Guillet C; Guazzi M
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
[TBL] [Abstract][Full Text] [Related]
16. [Effects of rilmenidine on the central nervous system and kidney].
Fillastre JP
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Scemama M; Février B; Beucler I; Dairou F
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
Panfilov V; Morris AD; Donnelly R; Reid JL
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension in diabetic patients.
Lambert AE; Mpoy M; Vandeleene B; Ketelslegers JM
Am J Med; 1989 Sep; 87(3C):30S-33S. PubMed ID: 2782324
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
Wilkinson R; Mansy S; Corcoran C
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
